New York State Common Retirement Fund Candel Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,700 shares of CADL stock, worth $9,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,700
Previous 1,700
-0.0%
Holding current value
$9,333
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CADL
# of Institutions
82Shares Held
15.2MCall Options Held
570KPut Options Held
203K-
Acorn Capital Advisors, LLC New York, NY2.58MShares$14.2 Million8.54% of portfolio
-
Northpond Ventures, LLC1.94MShares$10.6 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$9.81 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.62MShares$8.9 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA904KShares$4.96 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $159M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...